Delivery Order SPE2DB20D1100-SPE2DB24FB1G5
Award Date
4/4/24
Potential Completion Date
4/5/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is for the delivery of Briviact 100 mg tablets. The $3,410.56 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides medical supplies and pharmaceuticals to the U.S. Department of Defense. The contract has an ultimate completion date of March 19, 2024 and does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 25 mg tablets. The contract, valued at $2,484.06, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The $1,705.58 firm fixed-price contract is for the supply of Briviact 10 mg/ml oral solution in 300 ml bottles, with a period of performance through May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,028.77, is for the delivery of 4,564,161,074 tablets of the pharmaceutical product BRIVIACT 100 mg. The contract is a firm fixed price delivery order, with an ultimate completion date of April 4, 2024. No set-aside designation was used for this award. In addition...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,344.58, is for the delivery of Briviact 50 mg tablets over a period ending on November 6, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $11,595.24 firm fixed-price delivery order is for the supply of Briviact 50 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,410.56 Delivery Order contract is for the supply of Briviact 100 mg tablets, a prescription medication. The contract has a firm fixed price and an ultimate completion date of June 18, 2024. Amerisourcebergen, as a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,047.94, is for the supply of Briviact 50 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a value of $2,239.43, is for the procurement of the drug Briviact 50 mg tablets. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 50 mg tablets. The contract has a ceiling value of $4,281.65 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price delivery order contract, which means Amerisourcebergen will provide the specified pharmaceutical product at a pre-determined price. Amerisourcebergen holds a larger...